2nd Annual Early Phase Clinical Trials Asia 2012

Key Topics

• Alignment of pre-clinical models with optimised clinical strategies - a translational strategy
• Effective approaches to overcome regulatory challenges for early phase trial approval in China, India and Korea
• Optimization of trial design to effectively meet early phase study timelines
• Mitigation of risks and costs by designing a streamlined safety early phase study
• Effective modelling and simulation tools
• Outsourcing of strategies and partnership selection and maintenance with CROs
• Early phase trial with low availability of patients

Who should Attend

Directors, Heads and Managers of: Clinical Operations, Clinical Research, Clinical Pharmacology, Clinical Development, Clinical Project Managers, Medical Directors, Regulatory Affairs, Translational Medicine, Biomarker Development, Principle investigators and Clinical study design.